To continue our Summer Weekend Reads series, Cytel presents “Advancing Clinical Trials with Digital Tools: Simulation-Guided Design,” by CSO Yannis Jemiai, PhD; CMO Albert Kim, MD, PhD; VP of Product Marketing & Commercialization Joan Gaffney, MBA; and Associate Director of Content Marketing Esha Senchaudhuri, PhD. Please click below to access the full white paper.
When developing a clinical trial, much like embarking on a journey, the road ahead will include both known and unknown trajectories, obstacles, and roadblocks. So how can you confidently select the best path forward? Using massive compute power to sort through thousands of potential trial design variations in minutes and testing them against hundreds of hypothetical scenarios, Solara® can help development teams find the best route to reach their goals.
Our new white paper discusses how simulation-based statistical design can harness data to forecast risks, navigate uncertainties, align on internal goals, and produce pressure-tested clinical trial designs. The road map created allows trial strategists to avoid relying solely on conventional or familiar paths, and potentially missing the best route. And while simulation is an old tool, new technology is far more powerful and enables unparalleled insights.
Click to download our new white paper to learn more:
Read more from the Summer Weekend Read series:
If you'd like updates on our Summer Weekend Read series, sign up for email updates below.
